{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:58:09Z","timestamp":1765961889080,"version":"3.43.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,3]]},"DOI":"10.7759\/cureus.89289","type":"journal-article","created":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T18:18:02Z","timestamp":1754245082000},"source":"Crossref","is-referenced-by-count":2,"title":["Unveiling the Metabolic Burden: A Clinicopathological Study of Chronic Plaque Psoriasis and Its Association With Metabolic Syndrome"],"prefix":"10.7759","author":[{"given":"Siddharth","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjal","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monal L","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711060","article-title":"Metabolic syndrome and psoriasis: mechanisms and future directions","volume":"12","author":"Hao Y","year":"2021","unstructured":"Hao Y, Zhu YJ, Zou S, et al.. Metabolic syndrome and psoriasis: mechanisms and future directions. Front Immunol. 2021, 12:10.3389\/fimmu.2021.711060","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01408.x","article-title":"Psoriasis and metabolic syndrome","volume":"39","author":"Takahashi H","year":"2012","unstructured":"Takahashi H, Iizuka H. Psoriasis and metabolic syndrome. J Dermatol. 2012, 39:212-8. 10.1111\/j.1346-8138.2011.01408.x","journal-title":"J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03856.x","article-title":"Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants","volume":"25","author":"Mebazaa A","year":"2011","unstructured":"Mebazaa A, El Asmi M, Zidi W, et al.. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol. 2011, 25:705-9. 10.1111\/j.1468-3083.2010.03856.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08068.x","article-title":"Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review","volume":"157","author":"Sterry W","year":"2007","unstructured":"Sterry W, Strober BE, Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007, 157:649-55. 10.1111\/j.1365-2133.2007.08068.x","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72443","article-title":"Psoriasis in India: prevalence and pattern","volume":"76","author":"Dogra S","year":"2010","unstructured":"Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010, 76:595-601. 10.4103\/0378-6323.72443","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1079","article-title":"Psoriasis is associated with lipid abnormalities at the onset of skin disease","volume":"54","author":"Mallbris L","year":"2006","unstructured":"Mallbris L, Granath F, Hamsten A, St\u00e5hle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006, 54:614-21. 10.1016\/j.jaad.2005.11.1079","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021, 44:15-33. 10.2337\/dc21-S002","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-s219","article-title":"Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons","volume":"34","author":"Hermanides J","year":"2011","unstructured":"Hermanides J, Phillip M, DeVries JH. Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons. Diabetes Care. 2011, 34:197-201. 10.2337\/dc11-s219","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_420_23","article-title":"Disease assessment in psoriasis","volume":"68","author":"Manchanda Y","year":"2023","unstructured":"Manchanda Y, De A, Das S, Chakraborty D. Disease assessment in psoriasis. Indian J Dermatol. 2023, 68:278-81. 10.4103\/ijd.ijd_420_23","journal-title":"Indian J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285:2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000250839","article-title":"Severe psoriasis - oral therapy with a new retinoid","volume":"157","author":"Fredriksson T","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica. 1978, 157:238-44. 10.1159\/000250839","journal-title":"Dermatologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.131080","article-title":"Metabolic syndrome in patients with psoriasis: a comparative study","volume":"5","author":"Lakshmi S","year":"2014","unstructured":"Lakshmi S, Nath AK, Udayashankar C. Metabolic syndrome in patients with psoriasis: a comparative study. Indian Dermatol Online J. 2014, 5:132-7. 10.4103\/2229-5178.131080","journal-title":"Indian Dermatol Online J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven GM","year":"1988","unstructured":"Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988, 37:1595-607. 10.2337\/diab.37.12.1595","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi P","year":"2007","unstructured":"Gisondi P, Tessari G, Conti A, et al.. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007, 157:68-73. 10.1111\/j.1365-2133.2007.07986.x","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.72462","article-title":"Prevalence of metabolic syndrome in patients with psoriasis","volume":"76","author":"Nisa N","year":"2010","unstructured":"Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010, 76:662-5. 10.4103\/0378-6323.72462","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-90107-7_1","article-title":"Psoriasis: overview and diagnosis","author":"Kimmel GW","year":"2018","unstructured":"Kimmel GW, Lebwohl M. Psoriasis: overview and diagnosis. Evidence-Based Psoriasis. 2018, 1-16. 10.1007\/978-3-319-90107-7_1","journal-title":"Evidence-Based Psoriasis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/312463","article-title":"Prevalence of metabolic syndrome in patients with psoriasis","volume":"2012","author":"Zindanc\u0131 I","year":"2012","unstructured":"Zindanc\u0131 I, Albayrak O, Kavala M, Kocaturk E, Can B, Sudogan S, Ko\u00e7 M. Prevalence of metabolic syndrome in patients with psoriasis. Sci World J. 2012, 2012:10.1100\/2012\/312463","journal-title":"Sci World J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2012.24.1.11","article-title":"Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis","volume":"24","author":"Kim GW","year":"2012","unstructured":"Kim GW, Park HJ, Kim HS, et al.. Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis. Ann Dermatol. 2012, 24:11-15. 10.5021\/ad.2012.24.1.11","journal-title":"Ann Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.64.04.368","article-title":"Metabolic syndrome and psoriasis: a study in 97 patients","volume":"64","author":"Ferdinando LB","year":"2018","unstructured":"Ferdinando LB, Fukumoto PK, Sanches S, Fabricio LH, Skare TL. Metabolic syndrome and psoriasis: a study in 97 patients. Rev Assoc Med Bras (1992). 2018, 64:368-73. 10.1590\/1806-9282.64.04.368","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.183638","article-title":"Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: a hospital-based cross-sectional study","volume":"82","author":"Kothiwala SK","year":"2016","unstructured":"Kothiwala SK, Khanna N, Tandon N, Naik N, Sharma VK, Sharma S, Sreenivas V. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: a hospital-based cross-sectional study. Indian J Dermatol Venereol Leprol. 2016, 82:510-18. 10.4103\/0378-6323.183638","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb02687.x","article-title":"Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - relationships with disease severity","volume":"19","author":"Bonifati C","year":"1994","unstructured":"Bonifati C, Carducci M, Cordiali Fei P, Trento E, Sacerdoti G, Fazio M, Ameglio F. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - relationships with disease severity. Clin Exp Dermatol. 1994, 19:383-7. 10.1111\/j.1365-2230.1994.tb02687.x","journal-title":"Clin Exp Dermatol"},{"key":"ref22","article-title":"Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis","volume":"138","author":"Nickoloff BJ","year":"1991","unstructured":"Nickoloff BJ, Karabin GD, Barker JN, et al.. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 1991, 138:129-40.","journal-title":"Am J Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.12.1571","article-title":"Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome","volume":"144","author":"Chen YJ","year":"2008","unstructured":"Chen YJ, Wu CY, Shen JL, Chu SY, Chen CK, Chang YT, Chen CM. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol. 2008, 144:1571-5. 10.1001\/archderm.144.12.1571","journal-title":"Arch Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388793-unveiling-the-metabolic-burden-a-clinicopathological-study-of-chronic-plaque-psoriasis-and-its-association-with-metabolic-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T18:18:03Z","timestamp":1754245083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388793-unveiling-the-metabolic-burden-a-clinicopathological-study-of-chronic-plaque-psoriasis-and-its-association-with-metabolic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,3]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.89289","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,3]]}}}